Biography

Dr. Seidlin has the combination of scientific, clinical and business experience to assist clients in designing their own development programs or in evaluating candidates for licensing or investment.  The design and implementation of focused, strategic clinical development plans are the solution that optimizes both speed and cost.

Her fifteen years of experience in the pharmaceutical industry encompassed a wide variety of therapeutic areas including anti-infectives, CNS, GI and oncology and experience in all the key development regions and regulatory environments.  Her scientific and managerial responsibility in global clinical development in the pharmaceutical industry, culminating as President of the global clinical development subsidiary of a major Japanese Pharma company gave her a profound understanding of the business needs of development organizations in the context of today’s global pharmaceutical market.
 

Strengths include design and review of clinical development strategies across a broad range of therapeutic areas for both early and late stage projects, organizational development and management of a scientific organization in a multicultural environment. Experience also includes defense of products at FDA Advisory Committees, and expansion of franchise value for diverse products.  Management experience includes building and integrating global organizations and recruiting top talent for such organizations, and aligning global functions with empowered global project teams.

Dr. Seidlin received her AB in Biology and Biochemistry from Barnard College, Columbia University and MD from Harvard Medical School.  She was a fellow in the National Institutes of Allergy and Infectious Diseases and served as Assistant Clinical Professor of Medicine at New York University School of Medicine and Director of the AIDS Program at Bellevue Hospital.  She is Board Certified in Internal Medicine and Infectious Diseases.